Company Overview of Vanadis Diagnostics, AB
Vanadis Diagnostics, AB develops a solution for non-invasive prenatal testing (NIPT) based on digital analysis of cell-free DNA. The company develops Vanadis Smart NIPT, a non-invasive prenatal testing platform to simplify screening for trisomies 21, 18, and 13 by eliminating the need for complex DNA amplification and analysis. It enables pregnant women to receive reliable and accurate cell-free DNA based screenings through a method for healthcare providers. The company is based in Sollentuna, Sweden. Vanadis Diagnostics, AB operates as a subsidiary of PerkinElmer Sweden Health Sciences Holdings AB
46 8 40 80 59 56
Key Executives for Vanadis Diagnostics, AB
Vanadis Diagnostics, AB does not have any Key Executives recorded.
Similar Private Companies By Industry
|Abera Bioscience AB||Europe|
|Adenovir Pharma AB||Europe|
|Affibody Medical AB (publ)||Europe|
|Akinion Pharmaceuticals AB||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vanadis Diagnostics, AB, please visit www.vanadisdx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.